Levodopa
Showing 826 - 838 of 838
Parkinson Disease Trial in Australia, Italy, Spain (cabergoline, controlled-release levodopa / carbidopa)
Terminated
- Parkinson Disease
- cabergoline
- controlled-release levodopa / carbidopa
-
Westmead, New South Wales, Australia
- +13 more
May 24, 2007
Parkinson's Disease Trial in United States (Premarin ®)
Completed
- Parkinson's Disease
- Premarin ®
-
Sunnyvale, California
- +5 more
Dec 24, 2007
Idiopathic Parkinson's Disease Trial (Liatermin (r-metHuGDNF))
Completed
- Idiopathic Parkinson's Disease
- Liatermin (r-metHuGDNF)
- (no location specified)
Jan 10, 2008
Stimulus Rate on Cognitive and Motor Activity in Young Subjects,
Completed
- Parkinson's Disease
-
Bethesda, MarylandNational Institute of Neurological Disorders and Stroke (NINDS)
Mar 3, 2008
Functional Characterization of Parkin + Patients
Terminated
- Parkinson's Disease
-
Aix-en-Provence, France
- +13 more
Apr 18, 2007
Parkinson's Disease Trial (Electronic Monitoring cap)
Completed
- Parkinson's Disease
- Electronic Monitoring cap
- (no location specified)
Oct 16, 2006
Neurodegenerative Disease, Parkinson's Disease Trial run by the NINDS (dextromethorphan)
Completed
- Neurodegenerative Disease
- Parkinson's Disease
-
Bethesda, MarylandNational Institute of Neurological Disorders and Stroke (NINDS)
Jul 12, 2006
Parkinson's Disease Trial in New York (levodopa)
Completed
- Parkinson's Disease
- levodopa
-
New York, New YorkColumbia University Health Sciences
Jun 23, 2005
Growth Hormone-Releasing Hormone Antagonist on Growth Hormone
Completed
- Acromegaly
- (no location specified)
Jun 23, 2005
Motor State in Parkinson's Disease in Real Daily Life
Unknown status
- Parkinson's Disease
-
Nijmegen, NetherlandsRadboud university Nijmegen
Sep 12, 2005
Parkinson's Disease Trial in Rochester (Coenzyme Q10)
Completed
- Parkinson's Disease
- Coenzyme Q10
-
Rochester, New YorkUniversity of Rochester
Jun 23, 2005
Neuroendocrine Dysfunction in Patients With Closed Head Injuries
Unknown status
- Brain Injury
-
Galveston, Texas
- +1 more
Jun 23, 2005
Parkinson Disease Trial in New York (recombinant-methionyl human glial cell line-derived neurotrophic factor)
Completed
- Parkinson Disease
- recombinant-methionyl human glial cell line-derived neurotrophic factor
-
New York, New YorkDepartment of Neurology
Jun 23, 2005